Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

57.00 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
89 90 Next >
News headline image
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields ↗
 
Via Benzinga
News headline image
Is Pfizer Stock a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Laser-Focus on These Tariff-Proof Stocks Before It’s Too Late ↗
Stay calm amid tariff uncertainty with low-valued pharma and European stocks. Discover why these sectors offer protection and potential gains. 
Via InvestorPlace
Topics Government Intellectual Property World Trade
News headline image
Is Bristol Myers Squibb's High-Yielding Dividend Safe? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday. 
Via Chartmill
News headline image
Is Bristol-Myers Squibb Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Beat the S&P 500 With This Cash-Gushing Dividend Stock ↗
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
BMY: A High-Yielding Drug Stock With Great Growth Potential ↗
Bristol-Myers Squibb Co. traces its corporate beginnings back to 1887. Today, the company is a leader in developing innovative drugs like Eliquis for stroke prevention and Opdivo for cancer... 
Via Talk Markets
Topics Stocks / Equities
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
News headline image
5 Ways to Prepare for AI’s ‘Tower of Terror’ Moment ↗
As volatility rattles tech giants, investors are rotating into value stocks for stability and upside. Discover why this five-letter word could be the key to winning in 2025. 
Via InvestorPlace
Topics Artificial Intelligence Economy Government
News headline image
50-Year-Old Early Retiree Making $175,000 in Dividends Shares Portfolio - 'Now I Spend on Travel, Cars and Doing What I Want' ↗
 
Via Benzinga
News headline image
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
From Bristol Myers Squibb
Via Business Wire
News headline image
The 5-Letter Word Every Investor Should Memorize to Win in 2025 ↗
As volatility rattles tech giants, investors are rotating into value stocks for stability and upside. Discover why this five-letter word could be the key to winning in 2025. 
Via InvestorPlace
Topics Economy World Trade
News headline image
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
EQNX::TICKER_START (NYSE:ATNM),(NYSE:BMY),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
3 Deeply Discounted Dividend Stocks to Buy Today ↗
Via The Motley Fool
News headline image
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors ↗
Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival benefits in renal cancer. 
Via Benzinga
News headline image
1 Large-Cap Stock on Our Watchlist and 2 to Brush Off
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Topics Retirement
News headline image
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
BRISTOL-MYERS SQUIBB CO (NYSE:BMY): good value for what you're paying. ↗
BRISTOL-MYERS SQUIBB CO may be an undervalued stock option. NYSE:BMY retains a strong financial foundation and an attractive price tag. 
Via Chartmill
News headline image
The Stock Market Hates Uncertainty & Loves To Climb A Wall-Of-Worry ↗
In this video lesson, I review the overall market and a new swing position for Monday's session. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed ↗
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness. 
Via Benzinga
News headline image
2 High-Yield Dividend Stocks That Are Bargain Buys Right Now ↗
Via The Motley Fool
News headline image
Is BRISTOL-MYERS SQUIBB CO (NYSE:BMY) suited for dividend investing? ↗
Why BRISTOL-MYERS SQUIBB CO (NYSE:BMY) is a Top Pick for Dividend Investors. 
Via Chartmill
News headline image
Friday's session: top gainers and losers in the S&P500 index ↗
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Europe Approves Bristol Myers' Cell Therapy Breyanzi For Patients With Certain Type Of Blood Cancer ↗
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained efficacy. 
Via Benzinga
News headline image
These S&P500 stocks are gapping in today's session ↗
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Friday and stay ahead of the market trends. 
Via Chartmill
News headline image
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
From Bristol Myers Squibb
Via Business Wire
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
89 90 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.